Propanc Biopharma, Inc. PPCB
1.79 USD +0.08 (+4.68%)
At closeNov 4, 2026, 5:16 PM EST
1.78 -0.01 -0.56%
After hours · Nov 4, 5:16 PM ET
1.76 Day range 1.85
1.65 52-week range 315.00
- YTD
- -98.67%
- 1 year
- -99.32%
Latest period ending Jun 30, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| -18.19M | -57.28M | -1.54M | -1.78M | -1.99M | |
| -18.86M | -58.92M | -1.82M | -2.66M | -2.66M | |
| -176.00 | -3,712.00 | -355,132.00 | -26,999,995.00 | -738,449,852.00 |
Balance sheet
| Fiscal year | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| 832.01K | 12.09K | 21.09K | 10.05K | 4.07K | |
| 12.78M | 19.63M | 72.36K | 60.33K | 81.65K | |
| 3.38M | 5.73M | 3.85M | 3.18M | 3.11M | |
| 509.12K | 1.73M | 948.27K | 545.92K | 1.04M | |
| 9.40M | 13.91M | -3.78M | -3.12M | -3.02M |
Cash flow
| Fiscal year | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| -5.68M | -405.17K | -935.12K | -1.11M | -1.44M | |
| -4.93K | 0 | 0 | 0 | 0 | |
| 6.46M | 490.76K | 941.89K | 1.11M | 1.49M | |
| -4.93K | 0 | 0 | 0 | 0 | |
| 819.92K | -9.00K | 11.04K | 5.98K | 1.81K |